Trade gap narrows: Exports rise 7%, imports decline 10%

NEW DELHI: Goods exports rose 6.7% to $35.1 billion in Aug – possibly due to exporters advancing shipments to beat higher US tariffs – while imports dropped 10% to $61.6 billion, helping narrow the trade deficit.“Despite global uncertainty, the trade policy uncertainty, India’s exports have done extremely well. It shows that the policies have worked…

Read More

Govt asks e-tailers to promote GST rejig

MUMBAI: Govt has directed e-commerce firms to disseminate information about the GST reforms on their platforms. In a meeting held last week, it was suggested that platforms run a ‘GST Bachat Utsav’ campaign on their portals for 100 days starting Sept 22. Firms were also asked to reflect GST reduction in the bill. “All the…

Read More

AI startup Krutrim faces reality check

BENGALURU: What was once billed as India’s challenger to global giants in artificial intelligence and semiconductors has quietly dwindled into a shadow of those ambitions. Krutrim, the AI venture founded by Ola’s Bhavish Aggarwal, is now largely sustained by his personal wealth and loans tied to his Ola Electric stake, with most of its marquee…

Read More

Ex-Axis MF fund mgr pays Rs 86L, case shut

MUMBAI: Former Axis MF fund manager Deepak Agrawal has settled a regulatory case with Sebi by paying Rs 85.8 lakh and surrendering over 43,000 units. The case related to charges of financial misconduct, including sharing stock tips, passing on trading information, and failing to disclose directorships, which Sebi said amounted to violation of MF regulations….

Read More

WPI inflation swings into positive zone

NEW DELHI: Wholesale price inflation swung to positive territory in Aug after contracting for two months in a row as food and manufactured product prices inched up. Data released by the commerce and industry ministry on Monday showed inflation, as measured by the wholesale price index (WPI), rose to a four-month high of 0.5% in…

Read More

India revokes patent of Novartis’ cardiac drug

NEW DELHI: The Indian Patent Office (IPO) has revoked the patent on Novartis’ cardiac blockbuster drug Vymada on grounds of lack of novelty, potentially paving the way for affordable generics to enter the market.The popular therapy has been in the spotlight for years, with generic versions from Natco, Torrent Pharma, MSN Labs and Eris Lifesciences…

Read More